The Question
A 38-year-old man with no known medical history is brought to the emergency department by his partner due to two weeks of worsening headache, fevers, and confusion. His temperature is 38.4°C (101.1°F), blood pressure is 122/78 mm Hg, and heart rate is 104/min. On examination, he is lethargic and has nuchal rigidity. A non-contrast head CT shows no acute intracranial process. A lumbar puncture is performed, revealing an opening pressure of 35 cm H2O, a white blood cell count of 80/µL with a lymphocytic predominance, glucose of 30 mg/dL, and protein of 150 mg/dL. The cerebrospinal fluid cryptococcal antigen (CrAg) is positive. A newly obtained HIV-1 antibody test is also positive. His CD4 count is 22 cells/mm³, and his HIV-1 viral load is 350,000 copies/mL. He is admitted and started on intravenous amphotericin B and flucytosine. Which of the following is the most appropriate next step in management?
See the answer and explanation below:
Post-Call Recovery Reads
Finished your notes? Time to swap the pager for a crown. Kingdoms of Silent Sorrows is the ultimate 'brain-break', a high-stakes fantasy featuring a Fae princess, a Vampire king, and an enemies-to-lovers arc that will actually make you forget about your rounding list. No p-values, just fated mates and forbidden magic.
View on AmazonThe Correct Answer
A
Explanation
Clinical Pearl:
In patients with HIV-associated cryptococcal meningitis, antiretroviral therapy (ART) should be deferred for at least 4 to 6 weeks after initiating antifungal treatment to reduce the risk of life-threatening immune reconstitution inflammatory syndrome (IRIS) and associated mortality.
Explanation:
This patient has newly diagnosed AIDS (CD4 count < 200 cells/mm³) with cryptococcal meningitis, a life-threatening opportunistic infection. The cornerstone of initial treatment is induction antifungal therapy with a lipid formulation of amphotericin B and flucytosine. The most critical decision after starting antifungals is the timing of ART initiation. In the specific case of central nervous system cryptococcosis, early initiation of ART is associated with increased mortality. This is due to the development of IRIS, where a rapid recovery of the immune system triggers a massive inflammatory response to the cryptococcal antigens, leading to dangerously high intracranial pressure and clinical deterioration. Major clinical trials have demonstrated that deferring ART for 4 to 6 weeks is superior to immediate ART. Therefore, the correct approach is to complete the induction phase of antifungal therapy before starting ART. Immediate initiation of ART (B) is incorrect and has been shown to cause harm in patients with cryptococcal meningitis. Adding dexamethasone (C) is not recommended, as adjunctive corticosteroids have not been shown to improve outcomes in HIV-associated cryptococcal meningitis and may be detrimental. While managing elevated intracranial pressure is vital, daily therapeutic lumbar punctures (D) are not routinely indicated for all patients; they are performed as needed based on symptoms and persistently high opening pressures. Switching to fluconazole monotherapy (E) would be inappropriate de-escalation; the combination of amphotericin B and flucytosine is the standard induction therapy for this severe infection, after which a transition to high-dose fluconazole for consolidation is appropriate.
See you tomorrow morning!